A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

Adding pembrolizumab before and after surgery reduced recurrence and improved response in patients with locally advanced head ...

DelveInsight's "Metastatic Cutaneous Squamous Cell Cancer Market Insights, Epidemiology, and Market Forecast- 2032" report ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

This is the other story, one that describes a significant life challenge and tethers love, friendship, family, the power of ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and ...

The addition of chemotherapy to radiotherapy was not associated with improved survival among patients with intermediate-risk ...

Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...

The following is a summary of "ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is ...